Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial.

Sudhan DR, Schwarz LJ, Guerrero-Zotano A, Formisano L, Nixon MJ, Croessmann S, González Ericsson PI, Sanders M, Balko JM, Avogadri-Connors F, Cutler RE, Lalani AS, Bryce R, Auerbach A, Arteaga CL.

Clin Cancer Res. 2018 Oct 1. doi: 10.1158/1078-0432.CCR-18-1131. [Epub ahead of print]

PMID:
30274983
2.

A GC-MS untargeted metabolomics approach for the classification of chemical differences in grape juices based on fungal pathogen.

Schueuermann C, Steel CC, Blackman JW, Clark AC, Schwarz LJ, Moraga J, Collado IG, Schmidtke LM.

Food Chem. 2019 Jan 1;270:375-384. doi: 10.1016/j.foodchem.2018.07.057. Epub 2018 Jul 10.

PMID:
30174061
3.

ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.

Guerrero-Zotano AL, Stricker TP, Formisano L, Hutchinson KE, Stover DG, Lee KM, Schwarz LJ, Giltnane JM, Estrada MV, Jansen VM, Servetto A, Gavilá J, Perez-Fidalgo JA, Lluch A, Llombart-Cussac A, Bayar MA, Michiels S, André F, Arnedos M, Guillem V, Ruiz-Simon A, Arteaga CL.

Clin Cancer Res. 2018 Jun 1;24(11):2517-2529. doi: 10.1158/1078-0432.CCR-17-2904. Epub 2018 Mar 26.

PMID:
29581135
4.

An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression.

Schwarz LJ, Hutchinson KE, Rexer BN, Estrada MV, Gonzalez Ericsson PI, Sanders ME, Dugger TC, Formisano L, Guerrero-Zotano A, Red-Brewer M, Young CD, Lantto J, Pedersen MW, Kragh M, Horak ID, Arteaga CL.

J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx065.

PMID:
29059433
5.

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation.

Lee KM, Giltnane JM, Balko JM, Schwarz LJ, Guerrero-Zotano AL, Hutchinson KE, Nixon MJ, Estrada MV, Sánchez V, Sanders ME, Lee T, Gómez H, Lluch A, Pérez-Fidalgo JA, Wolf MM, Andrejeva G, Rathmell JC, Fesik SW, Arteaga CL.

Cell Metab. 2017 Oct 3;26(4):633-647.e7. doi: 10.1016/j.cmet.2017.09.009.

6.

Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer.

Formisano L, Stauffer KM, Young CD, Bhola NE, Guerrero-Zotano AL, Jansen VM, Estrada MM, Hutchinson KE, Giltnane JM, Schwarz LJ, Lu Y, Balko JM, Deas O, Cairo S, Judde JG, Mayer IA, Sanders M, Dugger TC, Bianco R, Stricker T, Arteaga CL.

Clin Cancer Res. 2017 Oct 15;23(20):6138-6150. doi: 10.1158/1078-0432.CCR-17-1232. Epub 2017 Jul 27.

7.

Selectivity mapping of the binding sites of (E)-resveratrol imprinted polymers using structurally diverse polyphenolic compounds present in Pinot noir grape skins.

Hashim SNNS, Schwarz LJ, Danylec B, Potdar MK, Boysen RI, Hearn MTW.

Talanta. 2016 Dec 1;161:425-436. doi: 10.1016/j.talanta.2016.08.059. Epub 2016 Aug 22.

PMID:
27769428
8.

Molecularly imprinted polymer membranes and thin films for the separation and sensing of biomacromolecules.

Boysen RI, Schwarz LJ, Nicolau DV, Hearn MT.

J Sep Sci. 2017 Jan;40(1):314-335. doi: 10.1002/jssc.201600849. Epub 2016 Oct 18. Review.

PMID:
27619154
9.

Recovery of ergosterol from the medicinal mushroom, Ganoderma tsugae var. Janniae, with a molecularly imprinted polymer derived from a cleavable monomer-template composite.

Hashim SN, Schwarz LJ, Danylec B, Mitri K, Yang Y, Boysen RI, Hearn MT.

J Chromatogr A. 2016 Oct 14;1468:1-9. doi: 10.1016/j.chroma.2016.09.004. Epub 2016 Sep 3.

PMID:
27658376
10.

Maybe we don't know JAK?

Schwarz LJ, Balko JM.

Mol Cell Oncol. 2016 May 31;3(4):e1192713. doi: 10.1080/23723556.2016.1192713. eCollection 2016 Jul.

11.

Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence.

Balko JM, Schwarz LJ, Luo N, Estrada MV, Giltnane JM, Dávila-González D, Wang K, Sánchez V, Dean PT, Combs SE, Hicks D, Pinto JA, Landis MD, Doimi FD, Yelensky R, Miller VA, Stephens PJ, Rimm DL, Gómez H, Chang JC, Sanders ME, Cook RS, Arteaga CL.

Sci Transl Med. 2016 Apr 13;8(334):334ra53. doi: 10.1126/scitranslmed.aad3001.

12.

Sequential molecularly imprinted solid-phase extraction methods for the analysis of resveratrol and other polyphenols.

Schwarz LJ, Danylec B, Harris SJ, Boysen RI, Hearn MT.

J Chromatogr A. 2016 Mar 18;1438:22-30. doi: 10.1016/j.chroma.2016.02.028. Epub 2016 Feb 10.

PMID:
26905880
13.

The Application of Template Selectophores for the Preparation of Molecularly Imprinted Polymers.

Danylec B, Schwarz LJ, Harris SJ, Boysen RI, Hearn MT.

Molecules. 2015 Sep 23;20(9):17601-13. doi: 10.3390/molecules200917601.

14.

LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.

Schwarz LJ, Fox EM, Balko JM, Garrett JT, Kuba MG, Estrada MV, González-Angulo AM, Mills GB, Red-Brewer M, Mayer IA, Abramson V, Rizzo M, Kelley MC, Meszoely IM, Arteaga CL.

J Clin Invest. 2014 Dec;124(12):5490-502. doi: 10.1172/JCI72573. Epub 2014 Nov 17.

15.

A comparison of covalent and non-covalent imprinting strategies for the synthesis of stigmasterol imprinted polymers.

Hashim SN, Boysen RI, Schwarz LJ, Danylec B, Hearn MT.

J Chromatogr A. 2014 Sep 12;1359:35-43. doi: 10.1016/j.chroma.2014.07.034. Epub 2014 Jul 19.

PMID:
25108765
16.

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.

Balko JM, Giltnane JM, Wang K, Schwarz LJ, Young CD, Cook RS, Owens P, Sanders ME, Kuba MG, Sánchez V, Kurupi R, Moore PD, Pinto JA, Doimi FD, Gómez H, Horiuchi D, Goga A, Lehmann BD, Bauer JA, Pietenpol JA, Ross JS, Palmer GA, Yelensky R, Cronin M, Miller VA, Stephens PJ, Arteaga CL.

Cancer Discov. 2014 Feb;4(2):232-45. doi: 10.1158/2159-8290.CD-13-0286. Epub 2013 Dec 19.

17.

Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.

Balko JM, Schwarz LJ, Bhola NE, Kurupi R, Owens P, Miller TW, Gómez H, Cook RS, Arteaga CL.

Cancer Res. 2013 Oct 15;73(20):6346-58. doi: 10.1158/0008-5472.CAN-13-1385. Epub 2013 Aug 21.

18.

Rapid solid-phase extraction and analysis of resveratrol and other polyphenols in red wine.

Hashim SN, Schwarz LJ, Boysen RI, Yang Y, Danylec B, Hearn MT.

J Chromatogr A. 2013 Oct 25;1313:284-90. doi: 10.1016/j.chroma.2013.06.052. Epub 2013 Jun 28.

PMID:
23871560
19.

Preparation of molecularly imprinted polymers for the selective recognition of the bioactive polyphenol, (E)-resveratrol.

Schwarz LJ, Danylec B, Harris SJ, Boysen RI, Hearn MT.

J Chromatogr A. 2011 Apr 22;1218(16):2189-95. doi: 10.1016/j.chroma.2011.02.043. Epub 2011 Feb 23.

PMID:
21411106
20.

Enrichment of (E)-resveratrol from peanut byproduct with molecularly imprinted polymers.

Schwarz LJ, Danylec B, Yang Y, Harris SJ, Boysen RI, Hearn MT.

J Agric Food Chem. 2011 Apr 27;59(8):3539-43. doi: 10.1021/jf104230f. Epub 2011 Mar 10.

PMID:
21391604

Supplemental Content

Loading ...
Support Center